pubrio
NMPA-National Medical Products Administration logo

NMPA-National Medical Products Administration

Government Agency
nmpa.gov.cn
Health And Human Services4 employeesFounded 1950🇨🇳 China

Main Responsibilities of the National Medical Products Administration (1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics. (2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system. (3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof. (4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA's responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.

Founded
1950
Employees
4
Industry
Health And Human Services
Company type
Government Agency
Headquarters
🇨🇳Beijing, Beijing
Specialties
Health And Human Services
4 / 13
Active markets
Hong Kong SAR China · Australia · Japan
2
New markets
Macao SAR China · Taiwan
Medium
Confidence
mostly early signals
+300%
Momentum
vs prior period
19 / 100
Expansion Score
Early
Stages12Exploring1Investing
5 signals · Last 90 days

Global expansion

Live
Hong Kong SAR ChinaAustraliaJapan
Stages
ExploringInvestingLandingOperating
+10more marketsLocked
3 of 13 shown

Unlock the market timeline & signal feed

Activity pulse

New Partnerships activity — 3 fresh signals just appeared.

Last 90 days
Hiring
0
No activity
Marketing & PR
0
No activity
Product & Tech
2
Product launch
+2more categoriesLocked
3 of 5 shown

Market entry timeline

The order this company entered each market — oldest to newest

1
🇭🇰Hong Kong SAR China1st market entered · 2025Advancing
Investing
14 signalsInvesting stage
2
🇦🇺Australia2nd market entered · 2025Advancing
Exploring
6 signalsExploring stage
3
🇯🇵Japan3rd market entered · 2025Advancing
Exploring
4 signalsExploring stage
+10more marketsLocked
3 of 13 shown
Current stageInvestingCommitting resources
Confidence41%Medium
Tracking since2025first signal

Recent signals

Product launch🇭🇰 Hong Kong SAR China2w ago

Antengene Receives CDE Endorsement for ATG-022 Phase III

Partnership🇭🇰 Hong Kong SAR Chinalast mo.

Kelun-Biotech Receives IND Approval for SKB118

Sign up to see the full signal feed

Good to know

Frequently Asked Questions Regarding NMPA-National Medical Products Administration

Quick answers about NMPA-National Medical Products Administration's business, markets, and growth signals.

Main Responsibilities of the National Medical Products Administration (1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics. (2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system. (3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof. (4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA's responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.